Jay Marumoto, MD
Sports Medicine · Honolulu, HINPI 1407968365
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Arthrex at 45.6% of the total. Reporting peaked in 2021 at $1,274 and has fallen 97.5% since, to $31 in 2025.
Across 23 payments — averaging $115.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Impactortho, Inc.$1K
- Bioventus LLC$193
- Ferring Pharmaceuticals Inc.$36
- Kowa Pharmaceuticals America, Inc.$13
What the payments were for
- Travel & lodging$49419%
- Food & beverage$95736%
- Education$1,20045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $1,208 |
| Impactortho, Inc. | 1 | $1,200 |
| Bioventus LLC | 8 | $193 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOLOGICS CONSUMABLES BONE REPAIR IOBP$120
- BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS BONE MARROW$102
How this compares
$2,650 in reported general payments places this provider in the 70th percentile of 31 sports medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 44 | $1,098 |
| Gabapentin | 98 | $1,080 |
| Oxycodone Hcl | 57 | $226 |
| Meloxicam | 21 | $196 |
| Mupirocin | 29 | $195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $105 |
| Methylprednisolone | 11 | $101 |
| Prednisone | 70 | $101 |
| Tramadol Hcl | 21 | $82 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $81 |
| Ondansetron Hcl | 17 | $71 |
| Cephalexin | 14 | $64 |
| Promethazine Hcl | 17 | $50 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Honolulu
- Jeffery HarpstriteHonolulu$153K
- Alexander GarberHonolulu$43K
- Daniel LimHonolulu$28K
- Megan KubaHonolulu$9K
- Jae YouHonolulu$8K
- Blane ChongHonolulu$2K
- Darryl KanHonolulu$2K
- Brandon TeruyaHonolulu$2K
- Garret NoguchiHonolulu$1K
- Elizabeth IgnacioHonolulu$574
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.